Moderna(us:MRNA)

    39.27

    -0.30%

    Updated on 2024-12-23

    Open:39.30
    Close:39.27
    High:40.34
    Low:38.52
    Pre Close:39.39
    Volume:3.37M
    Amount:133.32M
    Turnover:0.88%
    Shares:384.82M
    MarketCap:15.11B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3097826193234268.21%121323359
    2024-03-3194225933335267.71%108317361
    2023-12-3197125712721567.31%125265456
    2023-09-3099524364890764.02%78348431
    2023-06-30104124544811364.39%71296486
    2023-03-31109826868886370.05%104316507
    2022-12-31109924781600464.37%232291423
    2022-09-30100324244915962.65%74296464
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Baillie Gifford & Co4344904111.31%-1206776-2.70%
    2024-06-30Vanguard Group Inc3956279610.30%5259241.35%
    2024-06-30Blackrock Inc.255623216.66%1664430.66%
    2024-06-30Fmr Llc211612855.51%756144855.60%
    2024-06-30State Street Corp150239363.91%5719013.96%
    2024-06-30Theleme Partners Llp72268611.88%-94936-1.30%
    2024-06-30Geode Capital Management, Llc68914651.79%1409862.09%
    2024-06-30Morgan Stanley50065201.30%-487445-8.87%
    2024-06-30Flagship Pioneering Inc.46321491.21%-5033889-52.08%
    2024-06-30Wellington Management Group Llp43185711.12%-1286132-22.95%

    About

    Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
    Address:325 Binney Street

    Market Movers